Jun O. Liu

19.4k total citations · 3 hit papers
210 papers, 14.2k citations indexed

About

Jun O. Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun O. Liu has authored 210 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 65 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Jun O. Liu's work include Signaling Pathways in Disease (48 papers), Peptidase Inhibition and Analysis (42 papers) and Ubiquitin and proteasome pathways (19 papers). Jun O. Liu is often cited by papers focused on Signaling Pathways in Disease (48 papers), Peptidase Inhibition and Analysis (42 papers) and Ubiquitin and proteasome pathways (19 papers). Jun O. Liu collaborates with scholars based in United States, China and South Korea. Jun O. Liu's co-authors include Joong Sup Shim, Yongjun Dang, Shridhar Bhat, Curtis R. Chong, Hong‐Duk Youn, Daniel Romo, Edward Licitra, Robert A. Anders, Duojia Pan and Yi Liu‐Chittenden and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jun O. Liu

207 papers receiving 14.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

2012 1.1k citations Joong Sup Shim, Jun O. Liu et al. profile →
Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin

2010 717 citations Jun O. Liu et al. profile →
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth

2008 520 citations Yunzhao R. Ren, Jun O. Liu et al. Proceedings of the National Academy of Sciences profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jun O. Liu	8.9k	2.7k	1.9k	1.7k	1.5k	210	14.2k
Luiz Juliano	5.3k 0.6×	1.9k 0.7×	765 0.4×	1.4k 0.8×	1.1k 0.8×	389	11.2k
Maria Castedo	11.9k 1.3×	4.9k 1.8×	2.3k 1.2×	2.1k 1.3×	3.8k 2.5×	108	19.0k
Huib Ovaa	11.7k 1.3×	4.4k 1.6×	1.6k 0.9×	1.0k 0.6×	2.7k 1.8×	236	15.3k
Haian Fu	13.5k 1.5×	2.6k 0.9×	1.7k 0.9×	1.5k 0.9×	1.7k 1.2×	221	17.4k
Steven Grant	16.7k 1.9×	6.3k 2.3×	2.0k 1.1×	2.3k 1.4×	2.2k 1.5×	451	23.2k
Kapil N. Bhalla	17.3k 1.9×	5.9k 2.1×	1.8k 0.9×	2.2k 1.3×	2.8k 1.9×	378	26.0k
Yuri Lazebnik	14.7k 1.7×	3.7k 1.4×	1.8k 0.9×	2.2k 1.3×	3.4k 2.3×	53	19.3k
Gregory D. Cuny	6.9k 0.8×	1.3k 0.5×	856 0.5×	839 0.5×	1.9k 1.3×	165	11.5k
Lan Bo Chen	7.7k 0.9×	2.0k 0.7×	2.1k 1.1×	1.7k 1.0×	1.4k 0.9×	128	12.7k
Lorenzo A. Pinna	15.9k 1.8×	3.4k 1.2×	2.8k 1.5×	757 0.5×	1.4k 1.0×	448	21.6k

Countries citing papers authored by Jun O. Liu

Since Specialization

Citations

This map shows the geographic impact of Jun O. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun O. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun O. Liu more than expected).

Fields of papers citing papers by Jun O. Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun O. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun O. Liu. The network helps show where Jun O. Liu may publish in the future.

Co-authorship network of co-authors of Jun O. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jun O. Liu. A scholar is included among the top collaborators of Jun O. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun O. Liu. Jun O. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Biao, Wenhua Li, Xin Wang, et al.. (2025). Zinc finger protein Zfp335 is required for T cell homeostatic proliferation through regulating Lmnb1. Cell & Bioscience. 15(1). 139–139.

Chen, Shangsi, Jun O. Liu, Zhengyin Yan, et al.. (2025). When artificial intelligence (AI) meets organoids and organs-on-chips (OoCs): Game-changer for drug discovery and development?. 3(1). 100115–100115. 10 indexed citations

Wang, Jiahuan, et al.. (2024). Zinc oxide nanoparticles cause hepatotoxicity in rare minnow (Gobiocypris rarus) via ROS-mediated oxidative stress and apoptosis activation and inhibition of lipid peroxidation. Aquaculture Reports. 38. 102317–102317. 4 indexed citations

Qian, Shan, et al.. (2024). Insights into the structure–activity relationship of the anticancer compound ZJ-101: A role played by the amide moiety. Bioorganic & Medicinal Chemistry Letters. 105. 129741–129741. 2 indexed citations

Feng, Yanchun, Yingming Jiang, Jun O. Liu, et al.. (2023). Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma. Journal of Translational Medicine. 21(1). 738–738. 5 indexed citations

Qian, Shan, et al.. (2023). Synthesis and biological evaluation of biotinylated ZJ-101. Bioorganic & Medicinal Chemistry Letters. 91. 129372–129372. 1 indexed citations

Liu, Jun O., et al.. (2022). Total Synthesis of Rameswaralide Utilizing a Pharmacophore-Directed Retrosynthetic Strategy. Journal of the American Chemical Society. 144(40). 18575–18585. 20 indexed citations

Hurwitz, Lauren M., İbrahim Kulaç, Berrak Gümüşkaya, et al.. (2020). Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prevention Research. 13(10). 853–862. 7 indexed citations

Li, Yingjun, Kalyan Kumar Pasunooti, Hanjing Peng, et al.. (2020). Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors. ACS Medicinal Chemistry Letters. 11(6). 1111–1117. 4 indexed citations

10.

Lu, Tong, Qunfei Zhao, Emmanuel Datan, et al.. (2020). Triptolide: reflections on two decades of research and prospects for the future. Natural Product Reports. 38(4). 843–860. 105 indexed citations

11.

Liu, Jun O., et al.. (2019). Pharmacophore-Directed Retrosynthesis Applied to Rameswaralide: Synthesis and Bioactivity of Sinularia Natural Product Tricyclic Cores. Organic Letters. 21(18). 7394–7399. 22 indexed citations

12.

Liberti, Maria V., Annamarie E. Allen, Vijyendra Ramesh, et al.. (2019). Evolved resistance to partial GAPDH inhibition results in loss of the Warburg effect and in a different state of glycolysis. Journal of Biological Chemistry. 295(1). 111–124. 16 indexed citations

13.

Shim, Joong Sup, Namandjé N. Bumpus, Sarah A. Head, et al.. (2016). Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole. Clinical Cancer Research. 22(11). 2709–2720. 13 indexed citations

14.

Wilson, Brice A. P., Haofan Wang, Benjamin A. Nacev, et al.. (2011). High-Throughput Screen Identifies Novel Inhibitors of Cancer Biomarker α-Methylacyl Coenzyme A Racemase (AMACR/P504S). Molecular Cancer Therapeutics. 10(5). 825–838. 44 indexed citations

15.

Aftab, Blake T., Irina Dobromilskaya, Jun O. Liu, & Charles M. Rudin. (2011). Itraconazole Inhibits Angiogenesis and Tumor Growth in Non–Small Cell Lung Cancer. Cancer Research. 71(21). 6764–6772. 133 indexed citations

16.

Platz, Elizabeth A., Srinivasan Yegnasubramanian, Jun O. Liu, et al.. (2011). A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment. Cancer Discovery. 1(1). 68–77. 141 indexed citations

17.

Pan, Fan, Hong Yu, Eric V. Dang, et al.. (2009). Eos Mediates Foxp3-Dependent Gene Silencing in CD4 ⁺ Regulatory T Cells. Science. 325(5944). 1142–1146. 245 indexed citations

18.

Zhang, Yimao, Youngjoo Byun, Yunzhao R. Ren, et al.. (2009). Identification of Inhibitors of ABCG2 by a Bioluminescence Imaging–Based High-Throughput Assay. Cancer Research. 69(14). 5867–5875. 34 indexed citations

19.

Chen, Xiaochun, Curtis R. Chong, Lirong Shi, et al.. (2006). Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity. Proceedings of the National Academy of Sciences. 103(39). 14548–14553. 82 indexed citations

20.

Huai, Qing, Hwa-Young Kim, Yudong Liu, et al.. (2002). Crystal structure of calcineurin–cyclophilin–cyclosporin shows common but distinct recognition of immunophilin–drug complexes. Proceedings of the National Academy of Sciences. 99(19). 12037–12042. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact